Kiniksa Pharmaceuticals International, plc
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -85.3% | -85.3% | -67.8% |
| FY2022 | 46.3% | 46.3% | 39.9% |
| FY2023 | 3.2% | 3.2% | 2.7% |
| FY2024 | -9.9% | -9.9% | -7.4% |
| FY2025 | 10.4% | 10.4% | 7.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -85.3% | -85.3% | -67.8% |
| FY2022 | 46.3% | 46.3% | 39.9% |
| FY2023 | 3.2% | 3.2% | 2.7% |
| FY2024 | -9.9% | -9.9% | -7.4% |
| FY2025 | 10.4% | 10.4% | 7.7% |